IDR 990.0
(-1.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 29.49 Billion IDR | -38.16% |
2022 | 43.84 Billion IDR | -52.49% |
2021 | 92.29 Billion IDR | 168.35% |
2020 | 34.39 Billion IDR | 37.85% |
2019 | 24.94 Billion IDR | 118.64% |
2018 | 11.41 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 19.38 Billion IDR | 210.24% |
2024 Q3 | 8.11 Billion IDR | -13.17% |
2024 Q2 | 11.05 Billion IDR | -42.97% |
2023 Q2 | 6.53 Billion IDR | -31.31% |
2023 Q1 | 9.51 Billion IDR | -31.88% |
2023 FY | 27.11 Billion IDR | -38.16% |
2023 Q4 | 6.24 Billion IDR | 22.83% |
2023 Q3 | 5.08 Billion IDR | -22.22% |
2022 Q3 | 15.83 Billion IDR | 755.49% |
2022 Q2 | 1.85 Billion IDR | -85.64% |
2022 FY | 43.84 Billion IDR | -52.49% |
2022 Q1 | 12.89 Billion IDR | 438.33% |
2022 Q4 | 13.97 Billion IDR | -11.77% |
2021 Q1 | 37.11 Billion IDR | 64.72% |
2021 FY | 92.29 Billion IDR | 168.35% |
2021 Q4 | -3.81 Billion IDR | -114.48% |
2021 Q3 | 26.32 Billion IDR | -19.39% |
2021 Q2 | 32.66 Billion IDR | -12.0% |
2020 Q4 | 22.53 Billion IDR | 0.0% |
2020 FY | 34.39 Billion IDR | 37.85% |
2019 FY | 24.94 Billion IDR | 118.64% |
2018 FY | 11.41 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Bundamedik Tbk | 211.43 Billion IDR | 86.049% |
PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 181.623% |
PT Medikaloka Hermina Tbk | 780.69 Billion IDR | 96.222% |
PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | 97.556% |
PT Murni Sadar Tbk | 15.2 Billion IDR | -93.985% |
PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | 85.57% |
PT Royal Prima Tbk | -4.62 Billion IDR | 738.188% |
PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | 37.673% |
PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 98.293% |
PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | 72.241% |